Noxopharm Limited (ASX:NOX) New Data Confirms Cancer-Fighting Potential of Sofra™ Platform
26 May 2026 Price Sensitive Announcement $ Highlights: Overview: Noxopharm Limited, a clinical-stage biotech company focused on developing novel immune-modulating therapies, is pleased to announce new data demonstrating how the Sofra™...
